Audit 316343

FY End
2023-12-31
Total Expended
$58.84M
Findings
0
Programs
7
Year: 2023 Accepted: 2024-07-31

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.002 Bard $10.15M Yes 0
12.001 Dtra $7.52M Yes 0
12.002 Dtra $4.11M Yes 0
98.001 Usaid Foreign Assistance for Programs Overseas $264,077 Yes 0
12.420 Military Medical Research and Development $96,783 Yes 0
12.002 Dode $78,284 Yes 0
93.855 Allergy, Immunology and Transplantation Research $4,441 Yes 0

Contacts

Name Title Type
ZEJBC8JQM3P5 Louis Schwartz Auditee
2128471111 Ricardo Trujillo Auditor
No contacts on file

Notes to SEFA

Title: Note 1. Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. IAVI has elected not to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance. The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the Federal grant activity of IAVI under programs of the Federal Government for the year ended December 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of IAVI, it is not intended to and does not present the financial position, changes in net assets or cash flows of IAVI.
Title: Note 2. Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. IAVI has elected not to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. IAVI has elected not to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance.
Title: Note 3. Reconciliation of Schedule of Expenditures of Federal Awards to Financial Statements Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. IAVI has elected not to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance. Expenditures per the Schedule of Expenditures of Federal Awards $ 58,840,034 Non-Federal awards and fee for service arrangements 56,821,038 GRANTS AND CONTRIBUTIONS REVENUE WITHOUT DONOR RESTRICTIONS PER CONSOLIDATED STATEMENT OF ACTIVITIES $ 115,661,072